Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-07-13 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAMBERY (73000), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA GALOPPAZ : revenue, balance sheet and financial ratios
PHARMACIE DE LA GALOPPAZ is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAMBERY (73000),
this company of category PME
shows in 2025 a net income positive of 1 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA GALOPPAZ (SIREN 821652518)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
1 382 €
55 531 €
52 623 €
54 400 €
21 498 €
20 816 €
25 728 €
46 146 €
938 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA GALOPPAZ generates positive net income of 1 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 938 € -> 1 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 382 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 206%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
206.498%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
24.077%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA GALOPPAZ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1358.909
702.696
536.451
418.902
361.524
227.543
146.036
109.255
206.498
Financial autonomy
4.842
10.395
13.068
15.696
17.538
21.698
27.64
31.889
24.077
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
206.52025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average+6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA GALOPPAZ (206.50) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
24.08%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch
In 2025, the financial autonomy of PHARMACIE DE LA GALOPPAZ (24.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 90.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
90.973
Liquidity indicators evolution PHARMACIE DE LA GALOPPAZ
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
63.119
68.107
89.997
78.131
93.747
80.775
66.99
73.962
90.973
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
90.972025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch
In 2025, the liquidity ratio of PHARMACIE DE LA GALOPPAZ (90.97) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DE LA GALOPPAZ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA GALOPPAZ is estimated at
21 953 €
(range 14 897€ - 34 447€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
14k€21k€34k€
21 953 €Range: 14 897€ - 34 447€
NAF 5 année 2025
Valuation method used
Net Income Multiple
1 382 €
×
15.9x
=21 953 €
Range: 14 898€ - 34 448€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA GALOPPAZ with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA GALOPPAZ
What is the revenue of PHARMACIE DE LA GALOPPAZ ?
The revenue of PHARMACIE DE LA GALOPPAZ is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA GALOPPAZ profitable?
Yes, PHARMACIE DE LA GALOPPAZ generated a net profit of 1 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA GALOPPAZ ?
The headquarters of PHARMACIE DE LA GALOPPAZ is located in CHAMBERY (73000), in the department Savoie.
Where to find the tax return of PHARMACIE DE LA GALOPPAZ ?
The tax return of PHARMACIE DE LA GALOPPAZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA GALOPPAZ operate?
PHARMACIE DE LA GALOPPAZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart